October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

A recent study found that patients who had a positive fecal occult blood test (FOBT) but didn’t follow through with a colonoscopy had a fourfold higher risk for colorectal cancer (CRC) than the ...

Routine screening with fecal occult blood testing (FOBT) is associated with a decrease in colorectal cancer (CRC) mortality, according to a study published online Feb. 27 in JAMA Network Open.

When David Thau, a lobbyist in Washington, D.C., was 34, he periodically experienced pain in his stomach, irregular bowel movements, blood in his stool and vomiting, and he visited doctors who ...

A new study found fecal immunochemical testing is more effective than guaiac fecal occult blood testing and is often performed at a lower cost, according to findings published by the Journal of the ...

Fecal occult blood testing (FOBT) is a non-invasive screening tool designed to detect hidden blood in stool as an early indicator of colorectal neoplasia. Employed widely in organised screening ...

Please provide your email address to receive an email when new articles are posted on . Colorectal cancer incidence was four times higher among those who did not complete follow-up colonoscopy after ...

In an audio CME program on preventive care, the lecturer on prostate cancer stated that “prostate-specific antigen (PSA) is recommended for screening; digital rectal examination (DRE) has no real ...

Fecal immunochemical testing (FIT) is a non-invasive screening modality that quantifies haemoglobin levels in stool to detect occult bleeding from colorectal neoplasia. By offering a simple home-based ...

For permission requests, please contact NEJM Reprints at [email protected] Select the format you want to export the citation of this publication.